{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Vivimed Labs Ltd is Rated Strong Sell
Vivimed Labs Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 12 May 2026, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 29 September 2026, providing investors with the latest insights into its performance and prospects.
Vivimed Labs Falls 5.41%: 5 Key Events Driving the Volatile Week
Vivimed Labs Ltd experienced a turbulent week from 21 to 25 September 2026, closing down 5.41% at Rs.5.42 compared to the previous Friday’s close of Rs.5.73. This decline notably outpaced the Sensex’s modest 0.76% fall over the same period, reflecting persistent selling pressure and volatility in the micro-cap pharmaceutical stock. The week was marked by multiple circuit hits, alternating between intense selling and brief buying surges, underscoring fragile investor sentiment and liquidity constraints.
Below All Moving Averages and Now at Lower Circuit: Vivimed Labs Ltd Loses 0.92% in a Single Session
At Rs 5.5, sellers were still queuing — but there were no buyers willing to take the other side. Vivimed Labs Ltd locked at its lower circuit of 2% on 25 Sep 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity.
Vivimed Labs Ltd Locks at Upper Circuit With 1.68% Gain — Buyers Queue, Sellers Absent
At Rs 5.45, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Vivimed Labs Ltd locked at its upper circuit of 1.68% on 24 Sep 2026, with buyers queuing and no sellers willing to part with shares.
Vivimed Labs Ltd Locks at Upper Circuit With 1.49% Gain — Buyers Queue, Sellers Absent
At Rs 5.48, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Vivimed Labs Ltd locked at its upper circuit of 1.49% on 23 Sep 2026, with buyers queuing and no sellers willing to part with shares.
Vivimed Labs Ltd Locks at Lower Circuit With 1.83% Loss — Sellers Queue, No Buyers in Sight
At Rs 5.37, sellers were still queuing — but there were no buyers willing to take the other side. Vivimed Labs Ltd locked at its lower circuit of 1.83% on 22 Sep 2026, with unfilled sell orders and a frozen price.
Vivimed Labs Ltd Locks at Lower Circuit With 2% Loss — Sellers Queue, No Buyers in Sight
At Rs 5.47, sellers were still queuing — but there were no buyers willing to take the other side. Vivimed Labs Ltd locked at its lower circuit of 2% on 21 Sep 2026, with unfilled sell orders and a frozen price.
Vivimed Labs Ltd is Rated Strong Sell
Vivimed Labs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 18 September 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.
Vivimed Labs Ltd Locks at Lower Circuit With 1.93% Loss — Sellers Queue, No Buyers in Sight
At Rs 5.58, sellers were still queuing — but there were no buyers willing to take the other side. Vivimed Labs Ltd locked at its lower circuit of 1.93% on 18 Sep 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.
Vivimed Labs Ltd Locks at Lower Circuit With 1.9% Loss — Sellers Queue, No Buyers in Sight
At Rs 5.69, sellers were still queuing — but there were no buyers willing to take the other side. Vivimed Labs Ltd locked at its lower circuit of 1.9% on 17 Sep 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.
Vivimed Labs Ltd Locks at Lower Circuit With 2% Loss — Sellers Queue, No Buyers in Sight
At Rs 5.80, sellers were still queuing — but there were no buyers willing to take the other side. Vivimed Labs Ltd locked at its lower circuit of 2% on 16 Sep 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity.
Vivimed Labs Ltd Locks at Lower Circuit With 1.99% Loss — Sellers Queue, No Buyers in Sight
At Rs 5.91, sellers were still queuing — but there were no buyers willing to take the other side. Vivimed Labs Ltd locked at its lower circuit of 1.99% on 15 Sep 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.
Vivimed Labs Ltd Locks at Lower Circuit With 1.95% Loss — Sellers Queue, No Buyers in Sight
At Rs 6.03, sellers were still queuing — but there were no buyers willing to take the other side. Vivimed Labs Ltd locked at its lower circuit of 1.95% on 11 Sep 2026, with unfilled sell orders and a frozen price.
Vivimed Labs Ltd Locks at Lower Circuit With 1.9% Loss — Sellers Queue, No Buyers in Sight
At Rs 6.21, sellers were still queuing — but there were no buyers willing to take the other side. Vivimed Labs Ltd locked at its lower circuit of 1.9% on 9 Sep 2026, with unfilled sell orders and a frozen price.
Vivimed Labs Ltd Locks at Lower Circuit With 1.86% Loss — Sellers Queue, No Buyers in Sight
At Rs 6.33, Vivimed Labs Ltd locked at its lower circuit on 8 Sep 2026, reflecting a 1.86% decline within a 2% price band. Sellers were lined up to exit, but no buyers emerged to absorb the supply, resulting in unfilled sell orders and a frozen price — how severe is the selling pressure and what does it imply for liquidity?
Below All Moving Averages and Now at Lower Circuit: Vivimed Labs Ltd Loses 1.98% in a Single Session
At Rs 6.45, sellers were still queuing — but no buyers stepped forward. Vivimed Labs Ltd locked at its lower circuit of 2% on 7 Sep 2026, with unfilled supply forcing the price to freeze at the floor level.
Vivimed Labs Declines 5.66% Amid Circuit Hits and Selling Pressure: 5 Key Factors Driving the Drop
Vivimed Labs Ltd experienced a challenging week from 31 August to 4 September 2026, with its stock price declining 5.66% to close at ₹6.67, underperforming the Sensex which fell 1.11% over the same period. The stock faced significant volatility, hitting upper and lower circuit limits multiple times amid heavy selling pressure and thinning liquidity, reflecting heightened investor concerns and deteriorating sentiment despite some technical support at intermediate moving averages.
Vivimed Labs Ltd is Rated Strong Sell
Vivimed Labs Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 12 May 2026, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock’s current position as of 05 September 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Vivimed Labs Ltd Locks at Lower Circuit With 1.99% Loss — Sellers Queue, No Buyers in Sight
At Rs 6.41, sellers were still queuing — but there were no buyers willing to take the other side. Vivimed Labs Ltd locked at its lower circuit of 1.99% on 4 Sep 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
